8Lun·

$GXI (+1,16 %) Gerresheimer lowers growth forecast for 2024 and 2025 due to a significantly slower than expected market recovery in 2024 and lower than expected market growth in 2025 in the injection vials market.

The figures for the third quarter will be published on 10.10.24.

https://www.wallstreet-online.de/nachricht/18543557-gerresheimer-ag-wachstumsprognose-2024-2025

www.wallstreet-online.deNachrichten - Ad-hocs

4 Comentarios

DieEnte7@DieEnte7

8Lun

Hm, I think it's actually one of the most exciting German companies. If I didn't currently have any space in my portfolio, my fingers would be itching right now...

••

Brody@Brody

8Lun

@DieEnte7 Perhaps the future was painted a little too rosy in the past earnings. The tenor has always been that high customer inventories are currently still slowing down business, but that things will return to normal in the foreseeable future. In addition, the expansion of production capacities in the USA and Mexico to meet the demand for pens. This somehow contrasts with the fact that $1SXP is raising its growth target.
But I basically agree with you. It is already an attractive price.

•

DividendenMax@DividendenMax

3Semana

$UG1ZAT - of course I'm in there 💀

••

Brody@Brody

3Semana

@DividendenMax Ouch. $GXI under €50 is hefty.

••